期刊
JOURNAL OF PURCHASING AND SUPPLY MANAGEMENT
卷 21, 期 4, 页码 273-284出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.pursup.2015.04.006
关键词
R&D purchasing; R&D selling; Social capital; New product development; Biopharmaceutical industry
类别
This paper conceptualizes the supply chain of innovation of a company as its supply chain not related to physical goods exchanges but to R&D commodities exchanges. R&D commodities, being the outcomes of research activities, are for example patents, technologies, research services, studies, projects, etc. Specifically, we focus on the relationship between the activities of purchasing/selling R&D commodities and the propensity of the firm to develop new products; we examine how the position of the firm within its innovation network moderates this relationship. The empirical setting of the research consists of a cross-sectional dataset of 544 biopharmaceutical companies that have signed 1772 R&D agreements in the years 2006-2010. We find firstly, evidence of the supply chain of innovation (as a natural evolution of the well-acknowledged dual-market model of the biopharmaceutical industry). Secondly, we find that the relational embeddedness, coming from innovation network, influences the effect of purchasing and selling R&D commodities on new product development. Supporting our theoretical predictions, this paper offers contributions to the scientific literature on supply chain relationships in new product development. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据